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In recent years, scientists have created artificial microscopic and nanoscopic self-propelling particles, often referred to
as nano- or microswimmers, capable of mimicking biological locomotion and taxis. This active diffusion enables the
engineering of complex operations that so far have not been possible at the micro- and nanoscale. One of the most
promising tasks is the ability to engineer nanocarriers that can autonomously navigate within tissues and organs,
accessing nearly every site of the human body guided by endogenous chemical gradients. We report a fully synthetic,
organic, nanoscopic system that exhibits attractive chemotaxis drivenby enzymatic conversion of glucose.We achieve
this by encapsulating glucose oxidase alone or in combination with catalase into nanoscopic and biocompatible
asymmetric polymer vesicles (known as polymersomes). We show that these vesicles self-propel in response to an
external gradient of glucose by inducing a slip velocity on their surface, which makes them move in an extremely
sensitive way toward higher-concentration regions. We finally demonstrate that the chemotactic behavior of these
nanoswimmers, in combination with LRP-1 (low-density lipoprotein receptor–related protein 1) targeting, enables a
fourfold increase in penetration to the brain compared to nonchemotactic systems. from
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 INTRODUCTION
Directional locomotion or taxis is possibly one of the most important
evolutionary milestones, because it has enabled many living organisms
to outperform their nonmotile competitors. In particular, chemotaxis
(that is, themovement of organisms either toward or away from specific
chemicals) (1, 2) is possibly the most common strategy adopted by
many unicellular organisms to gather nutrients, escape toxins (3), and
help coordinate collective behaviors such as the formation of colonies
and biofilms (4). Chemotaxis is also exploited by multicellular systems
for tissue development (5), immune responses (6), or cancer metastasis
(7). It enables long-range interactions that extend over length scales that
are several orders ofmagnitude larger than themotile system itself (8). It
is not surprising that scientists have been trying to design devices that
mimic such a behavior (9–12). When swimming is scaled down to the
microscale, the fluid dynamics are dominated by viscous rather than
inertial forces (that is, Stokes regime). Under these conditions, propul-
sion is possible only by not-time-reversible deformations of the swim-
mer’s body (13,14) orby inducingaphoretic slip velocityon the swimmer’s
surface (15,16).The latter can, for example, beachievedbycreating thermal
gradients (thermophoresis) or chemical gradients of either charged
(electrophoresis) or neutral (diffusiophoresis) solutes in the swimmer’s
environment (15). Recently, it has in fact been proposed that the swim-
mer can induce a slip velocity on its surface by generating an asymmetric
distribution of reaction products that creates a localized chemical gradi-
ent. This concept known as self-diffusiophoresis was formalized theore-
tically (17) and demonstrated experimentally using latex particles (18)
and gold/silver rods (19).From a biotechnological point of view, self-propulsion can be ap-
plied to create carriers that are able to autonomously navigate within
biological fluids and environments. This could enable directed access
to nearly every site of the human body through blood vessels, indepen-
dent of the blood flow and local tissue architectures. In this respect,
recent preliminary experiments were performed with inorganic micro-
particles propelled by pH in the stomach of livingmice (20). The ability
to control active diffusion as a function of a physiological stimulus
bodes well for tackling challenges in drug delivery where an efficient
approach is yet to be found. Among these, the ability to deliver drugs
within the central nervous system (CNS) is one of the most difficult
tasks where current approaches only enable a small percentage of the
injected dose to reach the brain and the spinal cord (21, 22). The brain
and the rest of the CNS are well guarded by physiological barriers, with
the blood-brain barrier (BBB) being the most important. The BBB has
the dual function to protect the CNS and to ensure that it receives an
enhanced supply ofmetabolites. The brain is indeed themost expensive
organ in our body (23), consuming almost 20% of oxygen and glucose.
The latter is possibly one of themost important CNS nutrients (24), and
the BBB regulates its passage very effectively, with a consequent high
flow of glucose from the blood to the brain.
Here, we propose the design of an autonomous nanoscopic swim-
mer based on the combination of naturally occurring enzymes with
fully biocompatible carriers, known as polymersomes, that have already
been proven to hold great promise as drug and gene delivery vehicles
(25, 26). Specifically, to target the BBB and enter the CNS (27), we equip
polymersomes with the ability to self-propel in the presence of glucose
gradients.RESULTS AND DISCUSSION
Asymmetric polymersomes
Polymersomes are vesicles formed by the self-assembly of amphiphilic
copolymers in water (28). They have been proposed as an alternative to
liposomes (vesicles formed by naturally occurring phospholipids) be-
cause they offer greater flexibility over chemical and physical properties1 of 12
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 and allow large amounts of biological molecules, alone and in combi-
nation, including proteins and nucleic acids, to be compartmentalized
into nanoscale reactors (29, 30). Furthermore, we have demonstrated
(31–34) that, when two different copolymers are used to form one poly-
mersome, the resulting membrane segregates laterally into patterns
whose topology is strictly controlled by the molar ratio of the two co-
polymers and eventually coarsen into two separate domains forming
asymmetricpolymersomes (35).Here,we exploit this asymmetry to achieve
propulsion at the nanoscale. We mixed either poly[(2-methacryloyl)ethyl
phosphorylcholine]–poly[2-(diisopropylamino)ethyl methacrylate]
(PMPC-PDPA) or poly[oligo(ethylene glycol) methyl methacrylate]
(POEGMA)–PDPA with poly(ethylene oxide) poly(butylene oxide)
(PEO-PBO) copolymers. The copolymerswere selected on three different
complementaryproperties: (i) protein resistance for thehydrophilic blocks
PEO, POEGMA, and PMPC to hinder unspecific interactionwith plasma
proteins (opsonization) and limit rapid riddance from the immune system;
(ii) pH sensitivity for the PDPA to allow endosome escape and intracellular
delivery; and (iii) high permeability for the PBO to preferentially channel
both enzyme substrate and product diffusion. PMPC-PDPA and
POEGMA-PDPA have been established in vivo (36, 37), and whereas the
PMPC can be used directly to target scavenger receptor B overexpressed in
cancer cells (38), the POEGMA is inert in biological fluids and allows easy
conjugation to decorate polymersomewith ligands (27, 39) to target specific
cells. More relevantly, we show here that we can use POEGMA polymer-
somes as a platform for crossing the BBB and entering theCNSwhen com-
bined with the low-density lipoprotein receptor–related protein 1 (LRP-1)
targeting peptide Angiopep-2 (LA) (27). PEO-PBO forms very thin mem-
branes (~2.4 nm) (40) that are highly permeable tomost small polar mo-
lecules, such as hydrogenperoxide and glucose (41). The schematic of our
proposed design is shown in Fig. 1A. We have previously demonstrated
(32) that the two copolymers form asymmetric polymersomes at an op-Joseph et al., Sci. Adv. 2017;3 : e1700362 2 August 2017timal 9:1 molar ratio with the small permeable bud being formed by the
minor PEO-PBO component. This can be verified using transmission
electronmicroscopy (TEM) by imaging the polymersomes using positive
staining selective for the PDPA blocks [see Fig. 1 (B and C) for the
PMPC-PDPA/PEO-PBO and the POEGMA-PDPA/PEO-PBO mix-
tures]. As shown using negative staining TEM (Fig. 1D) where the
PBO domain is darker, the thickness of the two membranes can be
measured to be about 6.4 and 2.4 nm (for the PMPC-PDPA and
PEO-PBO domains respectively), confirming previously reported mea-
surements (25, 40). We have already demonstrated that PBO mem-
branes are 10 times more permeable than phospholipid ones (41) and
that these are at least 10 times less permeable than thick membranes
formed by aliphatic chains such as the PDPA ones (42). To a first ap-
proximation, we can thus infer that the PBOmembrane is two orders of
magnitude less permeable than the PDPA membrane. We can use such
an asymmetric polymersome to encapsulate enzymes using a technique
based on electroporation (30). We chose glucose oxidase to catalyze the
glucose oxidation to form D-glucono-d-lactone and hydrogen peroxide
and catalase to catalyze the decomposition of hydrogen peroxide into
water andoxygen. Both enzymes and reagents are naturally occurring in
the human body. As shown in fig. S1, we encapsulated an average of six
glucose oxidases and two catalases per polymersome either alone or in
combination.We thus hypothesize that, as the enzymes react with their
respective substrates, the confined reactions will produce a flux of
products that will be preferentially expelled out of the polymersomes
from the most permeable patch, that is, the bud formed by the minor
PEO-PBO component. This in turn generates a localized gradient of the
products that should set up the conditions for self-propulsion. The nature
of the propulsionmechanism depends on the interaction between the re-
action products and the two different polymersome domains (15). To a
first approximation, this should set the conditions for self-diffusiophoresis o
n
 August 10, 2017
ag.org/Fig. 1. Asymmetric polymersomes. (A) Schematic representation of a chemotactic polymersome using a combination of membrane topology formed by PEO-PBO
copolymers mixed with either PMPC-PDPA or POEGMA-PDPA copolymers. The polymersomes encapsulate glucose oxidase and/or catalase enzymes. (B) 9:1 PMPC-PDPA/PEO-PBO
polymersome imaged in positive staining exploiting the high affinity of PDPAwith the staining agent phosphotungstic acid (PTA). (C) 9:1 POEGMA-PDPA/PEO-PBO polymersome
imaged in the same staining agent for PDPA. (D) 9:1 PMPC-PDPA/PEO-PBO polymersome imaged in negative staining to highlight the differences in membrane thickness
between the PDPA and the PBO membrane.2 of 12
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 where the depletionof the productmolecules near the polymersome surface
induces a lateral water flow with slip velocity vS. Assuming a spherical
geometry of radiusR, the polymersomepropulsion translation and angular
velocity can be derived from the slip velocity asU=− 1/A∮AvSdA andW =
3/2RA∮A(vS × n)dA, respectively, where A is the total polymersome sur-
face area and n is the polymersome orientation unit vector. This vector
originates from the polymersome center of mass and is directed toward
the center of the asymmetric PEO-PBO domain. Both velocities can be
used to derive the general equations of motion expressed as a function of
the polymersome position r and orientation unit vector n as
∂r
∂t
¼ Uþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
kBT
3phR
s
WtðtÞ ð1Þ
∂n
∂t
¼ W nþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
kBT
4phR3
s
WrðtÞ  n ð2Þ
wherekB is theBoltzmannconstant,T is the absolute temperature,h is the
water viscosity,Wt andWr are the white noise vectors that respectively
model the translational and rotational Brownian diffusion of the
particle (15, 43).
Active diffusion analysis
To characterize the motility of the polymersomes, we have used a tech-
nique known as nanoparticle tracking analysis (NTA) (44). This is
based on the dark-field parallel tracking of thousands of single nano-
particles using a camera to detect the light of a monochromatic laser
scattered by the particles. The geometry of the observation chamber
is shown in fig. S2, and unless specified differently, we performed all
the measurements under physiological conditions, that is, T = 37°C,
hwater = 0.69 mPa, pH 7.4, in 100 mM phosphate-buffered saline
(PBS). The trajectories and the corresponding mean square displace-
ments (MSDs) can be used to evaluate the motility of the polymer-
somes. In figs. S3 to S13, we show 1-s trajectories (all normalized to a
common origin) and the corresponding MSDs for thousands of poly-
mersomes imaged at 30 frames per second (fps) under different environ-
mental conditions. In a homogeneous environment, either in the presence
or absence of the substrate, the results show that, independently of being
symmetric or asymmetric (loaded with enzymes or empty), the polymer-
somes have a typical Fickian diffusion profile with linear MSDs and
stochastic trajectories.Although theMSDsaveragedover thousandsof tra-
jectories (figs. S3 to S7) show some variations in the long-time diffusion
coefficient, these variations are mainly due to statistical fluctuations be-
tween different experimental realizations of the process. In particular,
we do not observe any appreciable enhancement in diffusivity. This sug-
gests that even if the enzymatic reaction creates an asymmetric distri-
bution of products around the loaded patchy polymersomes, with
consequent propulsion velocity, any corresponding directed part of
themotion is not sufficient to overcome the polymersomehigh rotational
diffusion due to its small size [z-average measured by dynamic light
scattering (DLS) R = 50 ± 10 nm; fig. S1], which effectively hinders any
self-propulsion by effectively randomizing the particles’ orientations in
t ≈ 0.5 ms, one order of magnitude below our experimental time reso-
lution (about 33.3 ms). To further confirm this, we calculated the ratio
between the enhanced diffusion coefficientDeff and the Stokes-Einstein
diffusion coefficient D0 from two-dimensional (2D) projections of
3D-simulated trajectories of chemotactic polymersomes. If, in first ap-
proximation, we assume thatW = 0, for a polymersome moving with aJoseph et al., Sci. Adv. 2017;3 : e1700362 2 August 2017propulsion velocity of 100 mms−1,Deff = 1.15D0, and for a polymersome
moving at 200 mm s−1, the Deff = 1.45D0. A detectable enhancement of
Deff = 2D0 corresponds to a propulsion velocity of 300 mm s
−1. These
calculations confirm that any enhancement in diffusion is small for real-
istic values of size and velocity in our system, thus making it difficult to
detect given the experimental variability. Both experiments and simula-
tions therefore suggest that the angular phoretic term proportional toW
in Eq. 2 is considerably smaller than theBrownian rotational component
and hence can be ignored hereafter.
We repeated the same set of experiments described in figs. S3 to S7 in
the presence of a concentration gradient created by adding the substrate
fromone sideof theobservationchamber (Fig. 2 and figs. S8 toS16).Under
the new experimental conditions, the symmetric polymersomes (either
loaded or empty) as well as the empty asymmetric polymersomes still
showed a typical Fickian diffusion profile with stochastic trajectories
and linear MSDs as a function of time. As a reference, Fig. 2A only
shows the data corresponding to the case of symmetric polymersomes
loaded with both glucose oxidase and catalase responding to a gradient
of glucose (generated by a 1M solution at the injection site), whereas the
other controlmeasurements are reported in figs. S3 to S16. The enzyme-
loaded asymmetric polymersomes instead responded quite differently
to the gradient of their respective substrate (Fig. 2, B to E). Figure 2B
shows the data for the asymmetric polymersomes loaded with catalase
alone (Cat) responding to a hydrogen peroxide gradient (generated by a
1 mM solution) coming from the right-hand side of the observation
chamber; the normalized trajectories are biased toward the gradient,
and the correspondingMSDs show a ballistic behavior with a quadratic
dependence on time. We limited our experiments to low concentration
of hydrogen peroxide to avoid its spontaneous decomposition and con-
sequent formation of oxygen bubbles that could dissolve the polymer-
somes, as shown recently by Jang et al. (45). Such superdiffusive
behavior is considerably more pronounced for the asymmetric poly-
mersomes loaded either with glucose oxidase alone (Gox) (Fig. 2C)
or glucose oxidase and catalase (Gox + Cat) together (Fig. 2, D and E),
responding to a glucose gradient generated by a 1M solution; almost all
the trajectories are aligned toward the gradient, whether this comes from
the right-hand (Fig. 2D) or the left-hand (Fig. 2E) side. This does not
change when, instead of using PMPC-PDPA polymersomes, we use
POEGMA-PDPA polymersomes, demonstrating that the differential
permeability of PDPA and PBO is responsible for the self-phoresis
(Fig. 2F). In addition to the trajectory and MSD analysis, the average
drift velocities are plotted in Fig. 2G as a function of the time of obser-
vation after the substrate addition. For Brownian particles such as those
in the control samples, the average drift velocity is zero, but as the samples
becomemore chemotactic, the drift velocity gradually increases. The var-
iation in drift velocity as a function of time after the addition of the
substrate allows us to estimate how self-propulsion behavior varies
with chemical gradient magnitude, and, in all cases, the drift velocity
equilibrates to a plateau value corresponding to the timewhen the gradi-
ent becomes linear (that is, ∇C ≈ constant) and the system reaches
steady-state conditions. This suggests that the rate of glucose diffusion
matches the time scale of propulsion. Finally, the distribution of par-
ticle orientation with respect to the direction of the substrate gradient is
plotted in Fig. 2H for all cases. Brownian samples (such as all the controls)
have directions almost equally distributed across all angles, whereas, as
the sample starts to exhibit propulsion and chemotaxis, the distribution
of particles polarizes toward the direction of the gradient. All the data
displayed in Fig. 2 show that, independently of the enzyme/substrate sys-
tem, asymmetric polymersomes show typical ballistic behavior with a3 of 12
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 chemotactic response toward the enzyme substrate gradient marked
hereafter as q = 0. The catalase-loaded polymersomes respond rather
weakly to the hydrogen peroxide gradient, and this is independent of
the peroxide initial tested concentrations. Glucose oxidase–loaded
asymmetric polymersomes, on the other hand, respond very strongly
to a glucose gradient, reachingdrift velocities around20mms−1withmost
particles polarized toward the gradient. Similar values are comparable to
those of chemotactic bacteria, such as Escherichia coli, which are one
order of magnitude larger than the polymersomes studied herein (4).
As shown in Fig. 1A, glucose oxidase and catalase operate very well
together because their respective reactions feed each other, with hydrogen
peroxide being a product of glucose dissociation and the oxygen being a
product of hydrogen peroxide dissociation (46). Furthermore, their com-
bination leads to the formation of nondetrimental molecules because
both oxygen and hydrogen peroxide are consumed and transformed into
water and D-glucono-d-lactone. Glucose oxidase self-regulates, and, as
a critical concentration of hydrogen peroxide is reached, its activity is
inhibited. This means that even at low H2O2 concentrations, we can
assume that catalase consumes most of the H2O2 (47). Most notably,
glucose oxidase– and catalase-loaded asymmetric polymersomes had the
strongest response to glucose gradients and produced slightly higher
drift velocities and considerably more polarized chemotaxis than the
system loaded with glucose oxidase or catalase alone. From these data,
we can conclude that no osmotic flow is generated, as demonstrated
by all control measurements in the supplementary figures and that (i)
the asymmetric distribution is critical, indeed symmetric polymersomes
(either made of PDPA or PBO membranes) loaded with enzymes did
not show any chemotactic drift; (ii) the reaction is critical, and emptyJoseph et al., Sci. Adv. 2017;3 : e1700362 2 August 2017polymersomes either symmetric or asymmetric do not exhibit any dif-
fusophoretic drift due only to the substrate gradient; and, finally, (iii)
only when the enzymes are encapsulated within an asymmetric poly-
mersome is chemotaxis exhibited, suggesting that the propulsion veloc-
ity is only proportional to the products∇Cp. These conclusions suggest
that, in the presence of a gradient, the strength of the polymersomes’
propulsion velocity is strongly biased by its orientation so as to create
an asymmetric angular probability in the particle’smotion that is higher
when the particle is oriented toward the gradient. The data in Fig. 2 are
the 2D projections of 3D trajectories on the field-of-view plane. To
simulate the same arrangement, we use a spherical polymersome with
R=50 nmand a smaller semispherical patch radius r= 15 nm, as shown
in Fig. 3A. We assume that the chemical gradient is aligned along the x
axis and that the orientation of the unit vector n is defined by a cone
within the sphere with aperture 2b. We can simulate the distribution of
the products’ concentration just outside the PBO permeable patch at
different orientations b (note S2.4.2), and this is expectedly biased toward
the chemical gradient as shown by the red line in Fig. 3A. We approxi-
mated this distribution with the function DCp = A(cos(b/2))
nint(2p/a),
where A is a proportionality constant and a is the sector angle of the
PBO domain. Because the gradient in the product distribution around
the particle is in first approximation proportional to such DCp (17, 18),
the propulsion velocity can be estimated from the data by describing its
functional formwith the samemodulation in the polymersome orienta-
tion. Such an approximation, together with the assumption that the
polymersome’s phoretic angular velocityW is negligible when compared
to its rotational diffusion, allows us to simulate the propulsion of the
polymersomes in the presence of the substrate gradient by using Eqs.Fig. 2. Active diffusion studies. Normalized 1s-trajectories and corresponding MSDs for (A) symmetric PMPC-PDPA polymersomes loaded with glucose oxidase (Gox)
and catalase (Cat) and responding to a glucose gradient (B) asymmetric PMPC-PDPA/PEO-PBO polymersomes loaded with catalase and responding to a hydrogen
peroxide gradient, (C) loaded with glucose oxidase and responding to a glucose gradient, (D to E) loaded with glucose oxidase and catalase responding to a glucose
gradient coming (D) from the right-hand side and (E) from the left-hand side and for (F) asymmetric POEGMA-PDPA/PEO-PBO polymersomes loaded with glucose
oxidase and catalase responding to a glucose gradient coming from the right-hand side. Blue arrows indicate the direction of the substrate gradient. Scale bars, 20 mm.
(G) The average drift velocity is plotted as a function of time after the substrate addition for the previous experiments. The error bars represents the SE calculated over
n = 3 measurements. (H) Degree of polarization of the corresponding trajectories towards the chemical gradient plotted as percentage of particles versus the gradient
angle. Perfect alignment with the gradient corresponds to q = 0°. The dashed lines represent the SEs.4 of 12
SC I ENCE ADVANCES | R E S EARCH ART I C L E1 and 2 (note S3). As shown in Fig. 3B, by fitting (solid lines) the ex-
perimental data (circles) with our model, we were able to estimate the
strength of the propulsion velocity for each formulation (Fig. 3C). The
(Gox + Cat) formulation is the one with the highest propulsion velocity,Joseph et al., Sci. Adv. 2017;3 : e1700362 2 August 2017and the formulationwith catalase alone in the presence of hydrogen per-
oxide is the one with the lowest value. The difference in performance
of the two enzymes/substrates is possibly due to the difference in sub-
strate concentration (considerably lower for the peroxide), which leads o
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 Fig. 3. Mechanism of chemotaxis. (A) Schematics of an asymmetric polymersome and its reference axis. We assumed the polymersome to be a sphere (R = 50 nm)
with a smaller patch (r = 15 nm and sector angle a); the angle b represents the orientation of the unit vector n with respect to the chemical gradient ∇C here aligned to
the x axis. We simulated the distribution of the products around the polymersome, and their normalized concentration is plotted (red line) alongside a fitting function
DCp = A(cos(b/2))
nint(2p/a) (blue line). n.u., normalized units. (B) Average MSDs for both experimental (circles) and simulated data (solid line) for asymmetric polymersomes
loaded with Gox and Cat responding to a glucose gradient (purple line and data) or in PBS (orange line and data), loaded with Gox and responding to a glucose gradient (blue
line and data), and loaded with Cat responding to a hydrogen peroxide gradient (red line and data). (C) Corresponding propulsion velocities calculated by the numerical
fittings for the three different combinations of enzymes and substrates. The lines represent the average values, whereas the bars represent the range of minimum and
maximum calculated velocity in the sample. (D) A total of 20 simulated trajectories of Gox + Cat–loaded polymersomes using the same temporal steps as in the experiments
(30 fps). These are shown as a 3D axonometric projection view and in the corresponding xy plane to show the comparison with the experimental data. (E) A single
simulated 3D trajectory shown with temporal steps of 33 ms (blue line) and 33 ms (orange line). The detail of a single trajectory is zoomed to show the succession of
reorientation and running steps of the polymersome diffusion. (F) Schematics of the proposed mechanisms of asymmetric polymersome chemotaxis, which consists of
an alternation of running and reorientation events.5 of 12
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all the different combinations, proving that the system we propose here
works with very different combinations of substrate/enzyme. The simu-
lations allow us to access the dynamics of propulsion with no limits in
both spatial and temporal resolution. In Fig. 3D, we show the simulated
3D trajectories normalized to a common origin of 20 polymersomes
with a temporal sampling identical to our experimental setting (that is,
33ms corresponding to a 30-fps acquisition rate).We show these both as
a 3D axonometric projection and in the corresponding xy plane view,
which reproduce very closely the experimental data in Fig. 2. In Fig.
3E, a single trajectory is plotted using both temporal resolution of
33 ms (blue line) and 33 ms (orange line) corresponding to a 30 × 105
and 3 × 105 fps acquisition rate, respectively. The polymersome trajec-
tories reveal that they are the result of a succession of running and re-
orientation events within the millisecond time scale, and hence, the
polymersomes quickly reorient toward the gradient with consequent
self-propulsion, as schematically represented in Fig. 3F.
Chemotaxis in complex environments
To get further insight into the chemotactic response of our system, we
performed further experiments on the polymersomes loaded with bothJoseph et al., Sci. Adv. 2017;3 : e1700362 2 August 2017enzymes tomore quantitatively assess their chemotactic capability using
the approach shown in Fig. 4A. A cylindrical agarose gel presoaked in
1 M glucose solution was placed on the edge of a petri dish filled with
PBS. Various polymersome formulations were added at the center of
the dish with a syringe pump. Samples were collected at different loca-
tions within the petri dish and at different time points as shown in Fig.
4B and quantified for concentration and sizing (fig. S17 and note S3).
InFig. 4 (C toE),we show the concentrationmapsof thepolymersomes in
the dish at time 0 min (Fig. 4C) and 10 min after their addition, both for
the symmetric formulation (Fig. 4D) and for the asymmetric formulation
(Fig. 4E) loadedwith glucose oxidase and catalase, in response to a glucose
gradient. We also studied a different configuration (note S3): a petri
dishprefilledwith fluorescent polymersomeswhere adropof 1Mglucose
solution is added in the center of the dish, which is directly imagedwith a
fluorescence camera (Fig. 4F). The corresponding fluorescence images of
both symmetric and asymmetric polymersomes before glucose addition
and at times t = 0, 10, and 15 min are shown. Whereas the first experi-
ment shows that the asymmetric polymersomes do not dilute in the pres-
ence of the glucose gradient and, instead, almost entirely drift toward
the glucose source (Fig. 4E), in the second experiment, we can observe
that the asymmetric polymersomes can concentrate toward the glucose o
n
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 Fig. 4. Collective chemotaxis. (A) Schematic of a petri dish where a cylindrical agarose gel soaked in glucose is placed. At time t = 0, a 1 mg ml−1 concentration of
polymersomes is added in the dish center, and their concentration is sampled at different locations as indicated by the sampling map in (B). The dot labeled with “S”
indicates the position of the source of glucose. (C to E) The resulting maps show the 2D distribution of asymmetric polymersomes (C) at time t = 0, and the distribution of
polymersomes at time t = 10 min for (D) symmetrical PMPC-PDPA and (E) asymmetrical PMPC-PDPA/PEO-PBO polymersomes loaded with catalase and glucose oxidase.
The isocratic white lines show the glucose gradient calculated by computational fluid dynamics. (F) A similar experiment is performed by adding glucose in the center of a
petri dish containing fluorescently labeled polymersomes after they have thermalized in it. The imaging is performed with a fluorescence camera. (G) The corresponding
fluorescence images are shown for both symmetric PMPC-PDPA and asymmetric PMPC-PDPA/PEO-PBO polymersomes loaded with catalase and glucose oxidase at dif-
ferent times: before the addition of glucose, at times t = 0, 10, and 15 min. The black bar indicates the needle for the injection of glucose over the imaging camera.6 of 12
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 gradient from high dilutions (Fig. 4G). These experiments show quite
convincingly that the chemotactic polymersomes follow shallow gradi-
ents and concentrate toward a given chemical source over time scales
of minutes and length scales 107 times longer than the swimmer’s
characteristic size. All the data bode well for bestowing polymersomes
with chemotactic capability and augmenting their efficiency innavigating
across biological barriers. To understand the effect of flow, we performed
the same experiments as in Fig. 2 but in the presence of a constant flow
almost perpendicular to the glucose gradient. The two chosen flow rates
of 0.5 and 3.5 ml min−1, corresponding to velocities of 10 and 150 mm s−1
(that is, Péclet number of 0.15 and 2.3, respectively), represent conditions
encountered next to the capillary barriers or right in the capillary center,
respectively. As shown in Fig. 5A, the normalized trajectories for both
pre–substrate addition and symmetric polymersomes show a typical
Gaussian distribution that is more skewed as the flow rate increases
from 0 to 3.5 ml min−1. At zero flow, the glucose oxidase– and catalase-
loaded polymersomes show a rapid response to the glucose gradient
with overall drift plateauing at about 20 min after the addition of glu-
cose. At a flow rate of 0.5 ml min−1, the chemotactic drift is still suffi-
ciently large to overcome the convection, and indeed, polymersomes
still move toward the glucose gradient, albeit at lower velocities. At a
flow rate of 3.5 ml min−1, the chemotactic drift combines with the flow,
inducing a drift of the polymersomes with trajectories taking a direction
of about 45° from the flow line. It is important to note (as shown in Fig.
5A) that as the flow increases, the gradient vector rotates from its orig-
inal unbiased position to being almost perpendicular to the flow. To test
the effect of placing chemotactic polymersomes in blood flow, we used
an agent-based model of the nanoparticles in capillaries in the presence
of erythrocytes (also known as red blood cells) that we have developed
previously (48). In Fig. 5B, we show a snapshot of the streamlines of the
flow observed in a capillarywith a radius of 4 mmand a length of 800 mm,
calculated by computational fluid dynamics (note S3). The red cylinders
represent erythrocytes (at physiological hematocritH%=10.7%), and the
colormaps show the normal velocity, that is, the velocity component per-
pendicular to the vessel wall. We used this geometry and seeded 100
nanoparticles randomly at the entrance of the vessel and allowed their
passage through the vessel. The vessel walls were set as no-slip, sticky
boundaries (that is, as a polymersome approaches the barrier it binds to
it), so that the number of nanoparticles bound to the vessel wall could be
evaluatedwithdifferent-sizedparticles and velocities of propulsion.As dis-
cussed above, we can assume that as asymmetric polymersomes
encounter a glucose gradient, they will propel with a propulsion velocity
that is directly proportional to the gradient, and their rotation is uniquely
controlled by Brownian dynamics. Assuming a glucose gradient across
the vessel, we performed the calculations for polymersomes with radius
R = 50, 100, and 250 nm, which is representative of a typical size
distribution of polymersomes (see DLS-measured distributions in fig.
S1), and to represent the spread of propulsion velocities (see both Figs.
2 and 3), we propelled the polymersomes from0 to 200 mms−1. Figure 5C
shows the percentage of particles that bind to the vessel wall during a
single passage. Binding to the vessel walls is generally improved by
increasing the propulsion velocity. Propulsion augments binding twofold
from 0 to 200 mm s−1 for small nanoparticles, and the binding to the wall
is considerably improved for the case of larger polymersomes and high
propulsion velocity reaching almost 100% of particles binding. Bigger
particles bind better to the wall than smaller particles do due to their
smaller rotational diffusion, which keeps the particles’ orientation along
the gradient for longer (12). Modeling would thus suggest that adding an
element of propulsion to the motion of the polymersomes increases theJoseph et al., Sci. Adv. 2017;3 : e1700362 2 August 2017overall uptake from the blood due to their improved distribution to the
endothelial wall interface. Furthermore, the use of glucose as a substrate
ensures that there is a high level of substrate available within the blood,
because blood glucose is maintained at 4 to 7.8 mM (24). In addition,
brainmetabolism requires high levels of glucose, and glucose transporters
are well known to be overexpressed on the BBB (24), and hence, it is not
farfetched to assume that blood glucose has a positive gradient toward the
blood wall and an evenmore favorable distribution within the brain. Re-
cently, we have demonstrated that polymersomes can be conjugatedwith
peptides that target the LRP-1 receptor. This receptor is overexpressed at
the BBB, and it is associatedwith a transportmechanismknown as trans-
cytosis. We have demonstrated that, by targeting this pathway, we can
deliver large macromolecules to CNS resident cells (27). LA-modified
asymmetric polymersomes can cross the BBB, and we showed this using
a 3D in vitro BBB model that comprises two cell types: brain endothelial
cells and pericytes cultured in the presence of conditionedmedium from
astrocytes. The endothelial cells are placed on the upper compart-
ment, and they are separated from the pericytes by a porous poly-
carbonate membrane (pores < 0.4 mm) (27). The geometry of the
model is shown in fig. S18A alongside with the qualitative (fig. S18B)
and quantitative (fig. S18C) kinetics of the polymersome BBB cross-
ing. These data show effective crossing and active pumping of the LA
polymersomes from the apical to the basolateral side of the BBB per-
formed by the endothelial cells. Moreover, the same in vitro model
can be used to evaluate the early time points, and as shown in Fig. 5D
and fig. S19, we observed that LRP-1–mediated transcytosis is extremely
fast, taking about 15 s from the binding event on the apical side to a full
crossing to the basolateral side.We have used this system to demonstrate
that chemotaxis can augment delivery significantly. This effect was vali-
dated in the rat CNS through in situ brain perfusion and quantification of
fluorescently labeled polymersomes in the different parts of the brain by
fractionation. Chemotactic polymersomes, responsive to glucose and
functionalized with LA, demonstrated about a fourfold delivery increase
into the parenchyma compared to nonchemotactic polymersome
controls, including LA-modified asymmetric empty polymersomes and
LA-symmetric polymersomes either loaded with Gox + Cat or empty
(Fig. 5E). The effective passage across the BBB is further demonstrated
by immunofluorescence histologies of the brain sectionswhose capillaries
are stainedusing theCD34marker (green); the cell nuclei are stainedwith
Hoechst (blue), and the polymersomes are labeled with Cy3 (red) as
shown in Fig. 5F. The nonactive polymersomes were optimized to reach
a respectable 5% of the injected dose. However, modifying the polymer-
somes, by adding an asymmetric patch and loading them with glucose
oxidase and catalase, enabled a staggering delivery of 20% of the injected
dose, which, to the best of our knowledge, has never been reported so far
with any other system. The glucose is a required metabolite in the blood,
and the brain consumes more than 20% of the assimilated glucose at any
given time. It is also established that the brain endothelial cells express
extremely high level of glucose transporters (49), suggesting that as the
blood reach the brain area, there must be a gradient from the center to
the wall of the vessel.CONCLUSIONS
We have shown here that an established intracellular delivery system
such as PMPC-PDPA and POEGMA-PDPA polymersomes can be
modified to have chemotactic capabilities toward glucose gradients.
We achieve this by using a novel process of converting a chemical
potential difference into an actual propulsion mechanism capable of7 of 12
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 tracking small-molecule gradients over distances that are many orders
of magnitude greater than the nanoparticle’s characteristic length. We
demonstrated that nanoscopic polymersomesmove according to super-
diffusional behaviors, and they do so only in the presence of a gradient
becoming chemotactic. This is achieved by protecting the actual molec-
ular machinery (the enzymes) within the polymersome aqueous lumen
away from immunological signaling and proteolytic degradations.WeJoseph et al., Sci. Adv. 2017;3 : e1700362 2 August 2017show that such a physical encapsulation enables high flexibility, and
we show that self-phoresis can be achieved using different combina-
tions of enzymes and substrates, with the only limiting factor being the
ability of the substrate to penetrate across the polymersome mem-
brane. We have shown that the combination of glucose oxidase and
catalase makes a very efficient chemotactic polymersome in the pres-
ence of a glucose gradient. Glucose oxidase and catalase work in tandemFig. 5. Chemotaxis under flow and in vivo. (A) Normalized polymersome 1-s trajectories measured in the presence of steady-state flow (0, 0.5, and 3.5 mm s−1) and
collected before and 1, 5, and 20min after the glucose gradient addition for both PMPC-PDPA/PEO-PBO asymmetric and PMPC-PDPA symmetric polymersomes loaded with
glucose oxidase and catalase. Red arrows denote the direction of the flow within the observation area, whereas the blue arrows denote the average direction of the glucose
gradientwithin it. Scale bars, 20mm.Pe, Péclet number. (B) Streamlines of flowobserved in a capillarywith a radius of 4 mmand a lengthof 800 mmcalculated by computational
fluid dynamics. The red cylinders represent erythrocytes (hematocritH%=10.7%), and the colormap shows the normal velocity of the flow, that is, the component perpendicular
to the vessel walls. (C) Simulated percentage of the total number of particles bound to the vessel surface as a function of their drift velocity in a gradient for 50-, 100-, and 250-nm
asymmetric nanoparticles calculated with an agent-based model of chemotactic particles within a capillary such as in (B). Note that the error bars show the SE. (D) Frequency
distributionof the crossing time fromapical tobasolateral of LA–POEGMA-PDPApolymersomesmeasuredover 35differentmeasurements using the in vitroBBBmodel as shown
in fig. S18 (note that one examplemeasurement is shown in fig. S19). (E) Percentage of the injected dose found in the rat brain parenchyma and the capillary fraction 10min
after carotid artery in situ perfusion of LA–POEGMA-PDPA/PBO asymmetric polymersomes loaded with Gox + Cat and empty and LA–POEGMA-PDPA symmetric polymersomes
loaded with Gox + Cat and empty, as well as pristine asymmetric POEGMA-PDPA/PEO-PBO polymersomes loaded with Gox and Cat (n = 6; ***P < 0.001 and ****P < 0.0001). The
error bars show the SE. n.s., not significant. (F) Immunofluorescence histologies of rat hippocampus sections of animals treated with LA–POEGMA-PDPA/PBO asymmetric
polymersomes loaded with Gox + Cat and pristine asymmetric POEGMA-PDPA/PEO-PBO polymersomes loaded with Gox and Cat.8 of 12
SC I ENCE ADVANCES | R E S EARCH ART I C L Eto create propulsion, transforming endogenous occurring glucose to en-
dogenous occurring D-glucono-d-lactone andwater, without the forma-
tion of potentially harmful compounds such as hydrogen peroxide and
gaseous oxygen. Finally, we demonstrate that with very minimal mod-
ification, we transform a well-established delivery system, the polymer-
some, into an efficient carrier that enables for the first time the use of
chemotaxis to augment biological barrier crossing. This is proved by
augmenting the delivery across the BBB, where we have demonstrated
an increase of almost fourfold in the amount of polymersomes gaining
access to the brain parenchyma of rats compared to BBB-targeting,
nonchemotactic polymersomes. This is a strong finding that we en-
vision will set a completely new trend in the design of drug delivery
systems embracing the new advances being proposed in active colloids. o
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 MATERIALS AND METHODS
Materials
Chemicals were used as received unless otherwise indicated. 2-
(Methacryloyloxy)ethyl phosphorylcholine (MPC > 99%) was donated
by Biocompatibles. 2-(Diisopropylamino)ethyl methacrylate (DPA)
was purchased from Scientific Polymer Products. Copper(I) bromide
(CuBr; 99.999%), 2,2′-bipyridine (bpy), methanol (anhydrous, 99.8%),
and isopropanol were purchased from Sigma-Aldrich. The silica used
for the removal of the atom transfer radical polymerization (ATRP) cop-
per catalyst was column chromatography grade silica gel 60 (0.063 to
0.200 mm) purchased from E. Merck. 2-(N-morpholino)ethyl 2-bromo-
2-methylpropanoate (ME-Br) initiator was synthesized according to
a previously reported procedure (50). Poly(ethylene glycol) methyl
ethermethacrylate [P(OEG10MA)]was purchased fromSigma-Aldrich.
PEO-PBO copolymer was purchased from Advanced Polymer Materials
Inc. The polymersomeswere labeled using rhodamine B octadecyl ester
perchlorate purchased from Sigma-Aldrich. PBSwasmade fromOxoid
tablets (one tablet per 100 ml of water). Bovine liver catalase, glucose
oxidase, and glucose have been purchased from Sigma-Aldrich. The
gel filtration column for the purification of the polymersomeswasmade
with Sepharose 4B purchased from Sigma-Aldrich.
PMPC25-PDPA70 copolymer synthesis
ThePMPC-b-PDPAdiblock copolymerwas prepared byATRP (50). In
a typical ATRP procedure, a Schlenk flask with amagnetic stir bar and a
rubber septum was charged with MPC (1.32 g, 4.46 mmol) and ME-Br
initiator (50.0mg, 0.178mmol) in ethanol (4ml) and purged for 30min
with N2. CuBr (25.6 mg, 0.178 mmol) and bpy ligand (55.8 mg,
0.358 mmol) were added as a solid mixture into the reaction flask.
The [MPC]/[ME-Br]/[CuBr]/[bpy] relative molar ratios were 25:1:1:2.
The reaction was carried out under a nitrogen atmosphere at 20°C.
After 60 min, deoxygenated DPA (6.09 g, 28.6 mmol) and methanol
(7 ml) mixture was injected into the flask. After 48 hours, the reaction
solution was diluted by the addition of ethanol (about 200 ml) and
then passed through a silica column to remove the copper catalyst.
The reactionmixturewas dialyzed against water to remove the organic
solvent and then freeze-dried. Finally, the copolymer molecular weight
was checked by nuclear magnetic resonance (NMR) analysis.
P(OEG10MA)20-PDPA100 copolymer synthesis
Theprotectedmaleimide initiator (Mal-Br)was prepared according to a
previously publishedprocedure (51). In a typical procedure, eitherME-Br
or Mal-Br initiators or ATRP initiators (0.105 mmol, 1 equiv.) were
mixedwithOEG10MA (1 g, 2.11mmol, 20 equiv.).When homogeneous,Joseph et al., Sci. Adv. 2017;3 : e1700362 2 August 20171 ml of water was added, and the solution was purged with nitrogen for
40 min. Then, a mixture of CuCl (10.4 mg, 0.105 mmol) and bpy
(32.9 mg, 0.210mmol) was mixed. After 8 min, a sample was removed,
and a nitrogen-purgedmixture ofDPA (2.2455 g, 0.0105mol, 100 equiv.)
mixed with 3 ml of isopropanol was added to the viscous mixture via
cannula. After 18 hours, the mixture was diluted with methanol. Then,
two volumes of dichloromethane were added. The solution was passed
through a column of silica using dichloromethane/methanol (2:1) to
remove the copper catalyst. The resulting solution was dialyzed [molecular
weight cutoff (MWCO) 1000] against ethanol and water and freeze-dried.
The resulting copolymer composition was determined by NMR analysis.
Copolymer conjugation with cysteine-terminated peptide
We dispersed the deprotected maleimide P(OEG10MA)20-PDPA100
(105.6mg,≅3.4 mmol ofmaleimide) in 4.5ml of nitrogen-purgedPBS at
pH7.3. The pHwas lowered by the addition of concentratedHCl (10ml)
to give a uniform solution. The pH was then increased to 7.8 with 5 M
NaOH, and the resulting opaque dispersion was sonicated for 10 min.
This solution (2.3 ml) was transferred to a second flask. Both solutions
were then purged with nitrogen for 10min (this should give an approx-
imate maleimide amount in each flask of 1.7 mmol). To the original so-
lution, we added Cys-Angiopep (5.5 mg, 2.3 mmol of thiol) followed by
tris(2-carboxyethyl)phosphine (2mg, 7 mmol). The pH in each solution
was measured to 7. Both solutions were left for 17 hours. Then, both
solutions were dialyzed against water (MWCO 8000) to remove any
excess peptide, followed by freeze-drying. Successful labeling was con-
firmed using a high-performance liquid chromatography (HPLC) with
fluorescence and absorption detection (contains fluorescent tyrosine
residues), rendering the polymer-peptide conjugates fluorescent at
303 nm when excited at 274 nm. On the other hand, the nonlabeled
polymer does not exhibit any fluorescence at these wavelengths (but
can be detected using the absorption detector).
Polymersome preparation
Nanometer-sized polymersomes were formed by the film rehydration
method (52, 53). The block copolymers were dissolved in 2:1 (v/v)
chloroform/methanol at a total copolymer concentration of 10 mg ml−1
in the organic solvent. Asymmetric polymersomes were obtained by
dissolving premixed copolymers at 90%PMPC25-PDPA70 or P(OEG10-
MA)20-PDPA100 and 10% PEO16-PBO22 inmolar ratio. Rhodamine B
in chloroform solution was added to the above solutions to create a
fluorophore final concentration of 50 mgml−1. Polymeric filmswere ob-
tained by drying the copolymer solutions in vacuumoven overnight. In
a typical experiment, 0.1 M PBS (pH 7.4) was added to the polymeric
films, and they were let stir for 30 days at room temperature to obtain
the formation of PEO-PBO domains on the PMPC-PDPA polymer-
somes surface. Topological asymmetry and size distribution have been
characterized by TEM and DLS analysis, respectively.
Transmission electron microscopy
APTAsolutionwasused as apositive andanegative stainingagentbecause
of its preferential interaction with the ester groups on the PMPC polymers
(54), which are not present in the PEO-PBO copolymer. The PTA staining
solution was prepared by dissolving 37.5 mg of PTA in boiling distilled
water (5 ml). The pH was adjusted to 7.4 by adding a few drops of 5 M
NaOH with continuous stirring. The PTA solution was then filtered
through a 0.2-mm filter. Then, 5 ml of polymersome/PBS dispersion was
deposited onto glow-discharged copper grids. After 1 min, the grids were
blottedwith filter paper and then immersed into the PTA staining solution9 of 12
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 for 5 s for positive staining and 10 s for negative staining. Then, the grids
were blotted again and dried under vacuum for 1min. Grids were imaged
using an FEI Tecnai G2 Spirit TEM microscope at 80 kV.
Dynamic light scattering
The sample was crossed by a 120-mW He-Ne laser at 630 nm at a
controlled temperature of 25°C, and the scattered light was measured
at an angle of 173°. For the analysis, the sample was diluted with filtered
PBS (pH 7) at a final concentration of 0.2mgml−1 into a final volume of
500 ml and then analyzed into a polystyrene cuvette (Malvern, DTS0012).
All DLS data were processed using a Dispersion Technology Software
(Malvern Instruments).
Reversed-phase HPLC
Reversed-phaseHPLC (RP-HPLC)wasperformedwithDionexUltiMate
3000 instrument equipped with variable wavelength detector to analyze
the ultraviolet absorption of the polymers at 220 nm and the enzyme sig-
nal at 280 nm. A gradient of H2O + trifluoroacetic acid was 0.05.
Enzyme encapsulation
Electroporation was used to allow the entrapment of glucose oxidase,
catalase, or the combination of the two within the polymersomes. The
optimal setting used for the electroporation was 10 pulses at 2500 V
(30). The number of enzymes that can be encapsulated is dictated by
the enzyme charge and size. As we demonstrated previously (30), the
loading can be modulated by changing the electroporation ac voltage
intensity and the number of pulses and by adjusting the enzyme sur-
face charges (for example, controlling the solution pH). After electro-
poration, the samples were purified by preparative gel permeation
chromatography. Then, the amount of polymer and encapsulated en-
zymes was quantified by RP-HPLC.
Encapsulation efficiency calculation
HPLC and DLS data were combined to calculate the number of poly-
mersomes produced in any experiment. The encapsulation efficiency
was defined as the number of molecules of enzyme loaded in each
polymersomes. The number of polymersomes in a sample can be es-
timated from the aggregation number (Nagg), which is defined as
Nagg ¼ 43 p
ðR lbÞ3  ðR lb  tmÞ3
nPDPA
ð3Þ
where R is the particle radius from the DLS, lb is the length of the hy-
drophilic PMPC brush, tm is the thickness of the PDPA membrane, and
nPDPA is the molecular volume of a single PDPA chain. The number of
polymersomes (Nps) in the sample is defined as
Nps ¼ ∑
n
i¼0
Nagg½PNaFiRi ð4Þ
where [P] is the moles of copolymer in the sample, Na is Avogadro’s
number, and FiRi is the fraction of sample at a defined radius R. Finally,
the encapsulation efficiency e is given by
e ¼ Ne
Nps
ð5ÞJoseph et al., Sci. Adv. 2017;3 : e1700362 2 August 2017where Ne is the number of enzymes in the sample. The average of
encapsulated enzymes per polymersome was 1.9 ± 0.25 for the catalase
and 6 ± 0.45 for the glucose oxidase. Results are shown in fig. S1 and
table S1.
NTA measurements of polymersomes diffusion
NTAwas performed with a NanoSight LM14 instrument equipped with
a Scientific CMOS camera mounted on an optical microscope to track
scattered light by particles illuminated by a focused (80 mm) beam gen-
erated by a singlemode laser diode (405 nm). The polymersome solution
(1 ml) was injected in a concentration of approximately 100 particles/ml
in PBS. Samples and controls were injected into the NanoSight chamber
as described in fig. S2. Two different populations of polymersomes
(asymmetric and symmetric) were analyzed with hydrogen peroxide/
glucose, depending on the loaded enzyme. Particles were tracked by
the built-in software for 60 seconds at 30 fps. The recorded tracks were
analyze usingMatlab. Origin of movement for all particles was normal-
ized to Cartesian coordinates (0,0). The MSD of all particles was
calculated as reported in Volpe et al. (43). Tracks were analyzed for
1 s. Particles not tracked for at least 1 s were discarded from the anal-
ysis. The average number of tracks per sample ranged from 2000 to
10,000 traces.
In vitro 3D cell culture BBB
For mouse brain endothelial cells [bEnd.3, American Type Culture
Collection (ATCC) CRL-2299], the medium used was Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal calf
serum (FCS), penicillin and streptomycin, L-glutamine, and fungi-
zone. Astrocyte (ATCC CRL-2541, C8-D1A Astrocyte type I clone)
medium was antibiotic-free DMEM supplemented with 10% FCS and
L-glutamine. Pericyte (mesenchymal stem cell, Gibco iMouse, C57BL/6)
medium used was DMEM F12 medium with GlutaMAX-I, supple-
mented with 10% FCS and gentamicin (5 mg ml−1). For transwell
experiments, both sides of the Transwell insert filters (Corning 3460
polyethylene filter; diameter, 1.05 cm; pore size, 0.4 mm) were pre-
coated with collagen (10 mg cm−2) for 2 hours at room temperature.
This was followed by seeding bEnd.3 endothelial cells on the upper
surface of the Transwell at a density of 20,000 to 40,000 cells per well
and incubated for 12 hours at 37°C in 95% air and 5%CO2 to allow the
cells to fully attach. Next, pericytes (10,000 to 20,000 cells per well)
were seeded on the opposite side of the filter insert and incubated
for 12 hours at 37°C in 95% air and 5% CO2. Finally, the inserts were
moved to a Transwell plate and incubated for 7 days at 37°C, with the
medium being changed every 2 days. Note that the medium was sup-
plemented with conditioned medium extracted from the astrocyte
culture. The endothelial tight junctions were stained with either anti–
ZO-1 or claudin-5, whereas pericytes were shown using anti-CD140.
For confocal imaging, the BBB models were fixed and imaged using
a z stack of 100 images with an optical slice of 0.4 mm. The concentra-
tion of polymersomes on the upper (apical) and lower (basolateral)
compartments was measured by HPLC using fluorescence detectors
collecting samples at different time points. For the early time point
and live cell kinetics, brain endothelial cells were treatedwithCellMASK
for 30 min and washed three times with PBS and immersed in imaging
medium (FluoroBrite DMEM) supplemented with 10% FCS and
gentamicin (5 mg ml−1). Polymersomes were subsequently added at
a concentration of 1 mg ml−1 into the apical (upper) Transwell com-
partment after transepithelial electric resistance measurements were
taken with an EVOM2 epithelial voltohmmeter. Cells were incubated10 of 12
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 for 1 to 2 hours at 37°C in 95% air and 5% CO2 and imaged on Leica
SP8 confocal laser scanning microscope with 40× water immersion
lens and 63× oil immersion lens. Rhodamine-labeled polymersomes
with an excitation wavelength of 561 nm was used, and fluorescence
emission wasmeasured at a wavelength of 575 to 600 nm. Cells’mem-
brane was stainedwithCellMASK. Image data were acquired and pro-
cessed using ImageJ software. We repeated this experiment three times
and measured a total of 35 crossing events
Brain in situ perfusion
Male adult Wistar rats were anaesthetized with ketamine (100 mg kg−1)
and medetomidine (1 mg kg−1) via intraperitoneal injection. The right
and left external carotid arteries were isolated from the carotid sheaths
and cannulated according to a previously established procedure (55). The
perfusion fluid was a modified Ringer’s solution [NaCl (6.896 g liter−1),
KCl (0.350g liter−1),CaCl2 (0.368g liter
−1),MgSO4(0.296g liter
−1),NaHCO3
(2.1 g liter−1), KH2O4 (0.163 g liter
−1), and Hepes (2.383 g liter−1), with
glucose (0.5005 g liter−1, 5.5 mM) and bovine serum albumin (BSA)
(11.1 g liter−1)]. Theperfusion fluidwas bubbledwith 5%CO2 andheated
to 37°C for 20min before perfusion. For the injection of polymersomes,
20% (mol) Cy3-labeled polymersomes in PBS with or without pro-
tein encapsulation were diluted to 1mgml−1 in Krebs buffer (pH 7.4)
[188 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mMMgSO4, 1.2 mM
KH2PO4, 25mMNaHCO3, 10mMD-glucose, andBSA (3 g liter
−1)]. The
polymersome solution was supplied via syringe pump at 0.16 ml min−1,
with a total perfusion rate of 1.5 ml min−1 and a total perfusion time of
10min. At the end of the perfusion time, the syringe pumpwas stopped,
and the arteries were flushed for 60 s with a modified Ringer’s per-
fusate to remove unboundpolymersomes.After 60 s, cerebrospinal fluid
was extracted via cisternal puncture followed by decapitation and re-
moval of the brain.
Quantification of polymersome distribution in the rat brain
After decapitation, brains were removed and washed in ice-cold NaCl
(9 g liter−1), followed immediately by homogenization on ice to initiate
the capillary depletion method (55). Briefly, the cerebellum was re-
moved, and the cerebrum was weighed, adding 2× brain weight in
PBS followed by 3× dilution in 30% (w/v) dextran (average MW
64,000 to 74,000). Centrifugation of homogenates at 7400g for 20 min
in 4°C resulted in several fractions that were carefully separated: capillary-
depleted (CD) fraction (that is, parenchyma), dextran, and the capillary-
enriched fraction (pellet). The capillary-enriched pellet was resuspended
in PBS, and 100 ml of the samples was added to a black 96-well plate and
read in a fluorimeter at an excitation wavelength of 540 nm and emission
at 565 nm. All sample fluorescence readings were normalized to readings
obtained from sham perfused rats (n = 6) for each sample type, that
is, CD, dextran, or capillaries. Positive controls were polymersomes in
perfusate harvested from the cannula at the injection point. Normalized
fluorescence readings were converted to a polymersome (Cy3) amount
that was converted into percentage injected dose %D of the positive
control value for that experiment, where %D = ds/dp%, where ds
is the normalized sample value (mg) and dp is the mean positive con-
trol value (mg). This was further converted into fluorescence per
whole brain. All statistical analyses were one-way analysis of variance
(ANOVA), P < 0.05. All animal studies were carried out according to
the ARRIVE (Animal Research: Reporting of In Vivo Experiments)
guidelines under licence from the UKHomeOffice (Scientific Procedures
Act 1986) and approved by the King’s College London ethical review
committee.Joseph et al., Sci. Adv. 2017;3 : e1700362 2 August 2017SUPPLEMENTARY MATERIALS
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fig. S1. Number of encapsulated enzyme and polymersome size distribution.
fig. S2. Schematic representation of the observation NanoSight chamber.
fig. S3. Asymmetric polymersomes loaded with catalase in the presence of homogeneously
dissolved hydrogen peroxide.
fig. S4. Asymmetric polymersomes loaded with glucose oxidase in the presence of
homogeneously dissolved glucose.
fig. S5. Asymmetric polymersomes loaded with catalase and glucose oxidase in the presence
of homogeneously dissolved glucose.
fig. S6. Symmetric polymersomes loaded with catalase and glucose oxidase after the injection
of PBS (that is, no gradient).
fig. S7. Asymmetric empty polymersomes after the injection of PBS (that is, no gradient).
fig. S8. Asymmetric polymersomes loaded with catalase and glucose oxidase after the
injection of PBS (that is, no gradient).
fig. S9. Symmetric PMPC-PDPA polymersomes loaded with catalase and glucose oxidase in the
presence of a glucose gradient.
fig. S10. Symmetric PEO-PBO polymersomes loaded with catalase and glucose oxidase in the
presence of a glucose gradient.
fig. S11. Asymmetric empty polymersomes in the presence of a glucose gradient.
fig. S12. Asymmetric empty polymersomes in the presence of a hydrogen peroxide gradient.
fig. S13. Asymmetric polymersomes loaded with catalase in the presence of a hydrogen
peroxide gradient.
fig. S14. Asymmetric polymersomes loaded with glucose oxidase in the presence of a glucose
gradient.
fig. S15. Asymmetric polymersomes loaded with catalase and glucose oxidase in the presence
of a glucose gradient.
fig. S16. Asymmetric PEO-PBO polymersomes loaded with catalase and glucose oxidase in the
presence of a glucose gradient.
fig. S17. Polymersome concentration in long-range chemotaxis.
fig. S18. BBB in vitro model for polymersome qualification.
fig. S19. Live cell imaging of LA polymersome real-time transcytosis.
table S1. Diffusion simulation parameters.
note S1. An agent-based model of nanoparticle propulsion in a capillary.
note S2. Long-range chemotaxis.
note S3. Simulation model and propulsion velocity fitting.
note S4. Diffusion simulations.REFERENCES AND NOTES
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